Identifying opportunities for the prevention of harmful use of alcohol, tobacco and other drugs among young Noongar (Aboriginal) people in the south-west of Western Australia

  • Research program: Aboriginal and Torres Strait Islander Health
  • Project status: Completed
  • Start date: January 2013
  • Expected end date: February 2015
  • Completion date: June 2015
  • Funded by: Australian National Preventative Health Agency
  • Lead organisation:

This was a collaborative project between the Southern Aboriginal Corporation and the National Drug Research Institute. It utilised a community consultation process to study alcohol, tobacco and other drug use among Aboriginal adolescents in a town in south-west Western Australia. This study identifies risk and resilience factors and opportunities for intervention and enable an Aboriginal community controlled organisation to develop an evidence-based strategy to address the harmful effects of substance use at a local level. The study has broad policy and practical implications and provides a template for action more broadly to address what is a significant health problem in Indigenous Australia. This project was funded by the Australian National Preventative Health Agency.

Name & Contact Details Role Research Program Location
Placeholder image

Dr Annalee Stearne
Tel: 61 (0)8 9266 1630
a.stearne@curtin.edu.au
View profile

Co-investigator

Alcohol policy and strategies

Perth

  • Co-investigator: Julia Butt, Edith Cowan University
  • Co-investigator: Edward Wilkes, Curtin University
  • Co-investigator: Mandy Wilson, Curtin University

Professor Dennis Gray
Professor
Tel: 61 (0)8 9266 1624
d.gray@curtin.edu.au
View profile

This project aligns with the following Sustainable Development Goals and Targets:

Kennedy, S., Carmody, T. and Stearne, A. (2014). Identifying opportunities for the prevention of harmful use of alcohol, tobacco and other drugs among young Noongars in Albany, Western Australia: Community Report. Southern Aboriginal Corporation, Albany and National Drug Research Institute, Curtin University, Perth, Western Australia. [T258] Download PDF